• レポートコード:QFJ1-4811 • 出版社/出版日:QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、105ページ • 納品方法:Eメール(納期:3日) • 産業分類:医療 |
Single User | ¥585,000 (USD3,900) | ▷ お問い合わせ |
Multi User | ¥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、腎除神経治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(高周波、超音波)、用途別市場規模(病院、外来手術センター、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。 ・市場概要 ・腎除神経治療の市場動向 ・企業の競争状況、市場シェア ・腎除神経治療の種類別市場規模と予測2016-2027(高周波、超音波) ・腎除神経治療の用途別市場規模と予測2016-2027(病院、外来手術センター、その他) ・腎除神経治療の北米市場規模2016-2027(アメリカ、カナダ) ・腎除神経治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等) ・腎除神経治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等) ・腎除神経治療の中南米市場規模2016-2027(メキシコ、ブラジル) ・腎除神経治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等) ・主要企業情報(Abbott、ReCor Medical、Boston Scientific、Cardiosonic、Medtronic、Kona medical、Mercator Medsystems、Terumo Corporation、Abbott Laboratories、Theragenics Corporation) ・結論 |
Renal denervation is a catheter-based minimally-invasive procedure. It is a therapy performed by radiofrequency or ultrasound ablation for uncontrolled hypertension.
Market Analysis and Insights: Global Renal Denervation Treatment Market
The global Renal Denervation Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Renal Denervation Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Renal Denervation Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Renal Denervation Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Renal Denervation Treatment market.
Global Renal Denervation Treatment Scope and Market Size
Renal Denervation Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Renal Denervation Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Radiofrequency
Ultrasound
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott
ReCor Medical
Boston Scientific
Cardiosonic
Medtronic
Kona medical
Mercator Medsystems
Terumo Corporation
Abbott Laboratories
Theragenics Corporation
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Renal Denervation Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Radiofrequency
1.2.3 Ultrasound
1.3 Market by Application
1.3.1 Global Renal Denervation Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Renal Denervation Treatment Market Perspective (2016-2027)
2.2 Renal Denervation Treatment Growth Trends by Regions
2.2.1 Renal Denervation Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Renal Denervation Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Renal Denervation Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Renal Denervation Treatment Industry Dynamic
2.3.1 Renal Denervation Treatment Market Trends
2.3.2 Renal Denervation Treatment Market Drivers
2.3.3 Renal Denervation Treatment Market Challenges
2.3.4 Renal Denervation Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Renal Denervation Treatment Players by Revenue
3.1.1 Global Top Renal Denervation Treatment Players by Revenue (2016-2021)
3.1.2 Global Renal Denervation Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Renal Denervation Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Renal Denervation Treatment Revenue
3.4 Global Renal Denervation Treatment Market Concentration Ratio
3.4.1 Global Renal Denervation Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Renal Denervation Treatment Revenue in 2020
3.5 Renal Denervation Treatment Key Players Head office and Area Served
3.6 Key Players Renal Denervation Treatment Product Solution and Service
3.7 Date of Enter into Renal Denervation Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Renal Denervation Treatment Breakdown Data by Type
4.1 Global Renal Denervation Treatment Historic Market Size by Type (2016-2021)
4.2 Global Renal Denervation Treatment Forecasted Market Size by Type (2022-2027)
5 Renal Denervation Treatment Breakdown Data by Application
5.1 Global Renal Denervation Treatment Historic Market Size by Application (2016-2021)
5.2 Global Renal Denervation Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Renal Denervation Treatment Market Size (2016-2027)
6.2 North America Renal Denervation Treatment Market Size by Type
6.2.1 North America Renal Denervation Treatment Market Size by Type (2016-2021)
6.2.2 North America Renal Denervation Treatment Market Size by Type (2022-2027)
6.2.3 North America Renal Denervation Treatment Market Size by Type (2016-2027)
6.3 North America Renal Denervation Treatment Market Size by Application
6.3.1 North America Renal Denervation Treatment Market Size by Application (2016-2021)
6.3.2 North America Renal Denervation Treatment Market Size by Application (2022-2027)
6.3.3 North America Renal Denervation Treatment Market Size by Application (2016-2027)
6.4 North America Renal Denervation Treatment Market Size by Country
6.4.1 North America Renal Denervation Treatment Market Size by Country (2016-2021)
6.4.2 North America Renal Denervation Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Renal Denervation Treatment Market Size (2016-2027)
7.2 Europe Renal Denervation Treatment Market Size by Type
7.2.1 Europe Renal Denervation Treatment Market Size by Type (2016-2021)
7.2.2 Europe Renal Denervation Treatment Market Size by Type (2022-2027)
7.2.3 Europe Renal Denervation Treatment Market Size by Type (2016-2027)
7.3 Europe Renal Denervation Treatment Market Size by Application
7.3.1 Europe Renal Denervation Treatment Market Size by Application (2016-2021)
7.3.2 Europe Renal Denervation Treatment Market Size by Application (2022-2027)
7.3.3 Europe Renal Denervation Treatment Market Size by Application (2016-2027)
7.4 Europe Renal Denervation Treatment Market Size by Country
7.4.1 Europe Renal Denervation Treatment Market Size by Country (2016-2021)
7.4.2 Europe Renal Denervation Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Renal Denervation Treatment Market Size (2016-2027)
8.2 Asia-Pacific Renal Denervation Treatment Market Size by Type
8.2.1 Asia-Pacific Renal Denervation Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Renal Denervation Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Renal Denervation Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Renal Denervation Treatment Market Size by Application
8.3.1 Asia-Pacific Renal Denervation Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Renal Denervation Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Renal Denervation Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Renal Denervation Treatment Market Size by Region
8.4.1 Asia-Pacific Renal Denervation Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Renal Denervation Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Renal Denervation Treatment Market Size (2016-2027)
9.2 Latin America Renal Denervation Treatment Market Size by Type
9.2.1 Latin America Renal Denervation Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Renal Denervation Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Renal Denervation Treatment Market Size by Type (2016-2027)
9.3 Latin America Renal Denervation Treatment Market Size by Application
9.3.1 Latin America Renal Denervation Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Renal Denervation Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Renal Denervation Treatment Market Size by Application (2016-2027)
9.4 Latin America Renal Denervation Treatment Market Size by Country
9.4.1 Latin America Renal Denervation Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Renal Denervation Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Renal Denervation Treatment Market Size (2016-2027)
10.2 Middle East & Africa Renal Denervation Treatment Market Size by Type
10.2.1 Middle East & Africa Renal Denervation Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Renal Denervation Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Renal Denervation Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Renal Denervation Treatment Market Size by Application
10.3.1 Middle East & Africa Renal Denervation Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Renal Denervation Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Renal Denervation Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Renal Denervation Treatment Market Size by Country
10.4.1 Middle East & Africa Renal Denervation Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Renal Denervation Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Renal Denervation Treatment Introduction
11.1.4 Abbott Revenue in Renal Denervation Treatment Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 ReCor Medical
11.2.1 ReCor Medical Company Details
11.2.2 ReCor Medical Business Overview
11.2.3 ReCor Medical Renal Denervation Treatment Introduction
11.2.4 ReCor Medical Revenue in Renal Denervation Treatment Business (2016-2021)
11.2.5 ReCor Medical Recent Development
11.3 Boston Scientific
11.3.1 Boston Scientific Company Details
11.3.2 Boston Scientific Business Overview
11.3.3 Boston Scientific Renal Denervation Treatment Introduction
11.3.4 Boston Scientific Revenue in Renal Denervation Treatment Business (2016-2021)
11.3.5 Boston Scientific Recent Development
11.4 Cardiosonic
11.4.1 Cardiosonic Company Details
11.4.2 Cardiosonic Business Overview
11.4.3 Cardiosonic Renal Denervation Treatment Introduction
11.4.4 Cardiosonic Revenue in Renal Denervation Treatment Business (2016-2021)
11.4.5 Cardiosonic Recent Development
11.5 Medtronic
11.5.1 Medtronic Company Details
11.5.2 Medtronic Business Overview
11.5.3 Medtronic Renal Denervation Treatment Introduction
11.5.4 Medtronic Revenue in Renal Denervation Treatment Business (2016-2021)
11.5.5 Medtronic Recent Development
11.6 Kona medical
11.6.1 Kona medical Company Details
11.6.2 Kona medical Business Overview
11.6.3 Kona medical Renal Denervation Treatment Introduction
11.6.4 Kona medical Revenue in Renal Denervation Treatment Business (2016-2021)
11.6.5 Kona medical Recent Development
11.7 Mercator Medsystems
11.7.1 Mercator Medsystems Company Details
11.7.2 Mercator Medsystems Business Overview
11.7.3 Mercator Medsystems Renal Denervation Treatment Introduction
11.7.4 Mercator Medsystems Revenue in Renal Denervation Treatment Business (2016-2021)
11.7.5 Mercator Medsystems Recent Development
11.8 Terumo Corporation
11.8.1 Terumo Corporation Company Details
11.8.2 Terumo Corporation Business Overview
11.8.3 Terumo Corporation Renal Denervation Treatment Introduction
11.8.4 Terumo Corporation Revenue in Renal Denervation Treatment Business (2016-2021)
11.8.5 Terumo Corporation Recent Development
11.9 Abbott Laboratories
11.9.1 Abbott Laboratories Company Details
11.9.2 Abbott Laboratories Business Overview
11.9.3 Abbott Laboratories Renal Denervation Treatment Introduction
11.9.4 Abbott Laboratories Revenue in Renal Denervation Treatment Business (2016-2021)
11.9.5 Abbott Laboratories Recent Development
11.10 Theragenics Corporation
11.10.1 Theragenics Corporation Company Details
11.10.2 Theragenics Corporation Business Overview
11.10.3 Theragenics Corporation Renal Denervation Treatment Introduction
11.10.4 Theragenics Corporation Revenue in Renal Denervation Treatment Business (2016-2021)
11.10.5 Theragenics Corporation Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Renal Denervation Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Radiofrequency
Table 3. Key Players of Ultrasound
Table 4. Global Renal Denervation Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Renal Denervation Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Renal Denervation Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Renal Denervation Treatment Market Share by Regions (2016-2021)
Table 8. Global Renal Denervation Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Renal Denervation Treatment Market Share by Regions (2022-2027)
Table 10. Renal Denervation Treatment Market Trends
Table 11. Renal Denervation Treatment Market Drivers
Table 12. Renal Denervation Treatment Market Challenges
Table 13. Renal Denervation Treatment Market Restraints
Table 14. Global Renal Denervation Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Renal Denervation Treatment Market Share by Players (2016-2021)
Table 16. Global Top Renal Denervation Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Renal Denervation Treatment as of 2020)
Table 17. Ranking of Global Top Renal Denervation Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Renal Denervation Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Renal Denervation Treatment Product Solution and Service
Table 21. Date of Enter into Renal Denervation Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Renal Denervation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Renal Denervation Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Renal Denervation Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Renal Denervation Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Renal Denervation Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Renal Denervation Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Renal Denervation Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Renal Denervation Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Renal Denervation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Renal Denervation Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Renal Denervation Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Renal Denervation Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Renal Denervation Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Renal Denervation Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Renal Denervation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Renal Denervation Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Renal Denervation Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Renal Denervation Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Renal Denervation Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Renal Denervation Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Renal Denervation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Renal Denervation Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Renal Denervation Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Renal Denervation Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Renal Denervation Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Renal Denervation Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Renal Denervation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Renal Denervation Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Renal Denervation Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Renal Denervation Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Renal Denervation Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Renal Denervation Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Renal Denervation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Renal Denervation Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Renal Denervation Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Renal Denervation Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Renal Denervation Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Renal Denervation Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbott Company Details
Table 62. Abbott Business Overview
Table 63. Abbott Renal Denervation Treatment Product
Table 64. Abbott Revenue in Renal Denervation Treatment Business (2016-2021) & (US$ Million)
Table 65. Abbott Recent Development
Table 66. ReCor Medical Company Details
Table 67. ReCor Medical Business Overview
Table 68. ReCor Medical Renal Denervation Treatment Product
Table 69. ReCor Medical Revenue in Renal Denervation Treatment Business (2016-2021) & (US$ Million)
Table 70. ReCor Medical Recent Development
Table 71. Boston Scientific Company Details
Table 72. Boston Scientific Business Overview
Table 73. Boston Scientific Renal Denervation Treatment Product
Table 74. Boston Scientific Revenue in Renal Denervation Treatment Business (2016-2021) & (US$ Million)
Table 75. Boston Scientific Recent Development
Table 76. Cardiosonic Company Details
Table 77. Cardiosonic Business Overview
Table 78. Cardiosonic Renal Denervation Treatment Product
Table 79. Cardiosonic Revenue in Renal Denervation Treatment Business (2016-2021) & (US$ Million)
Table 80. Cardiosonic Recent Development
Table 81. Medtronic Company Details
Table 82. Medtronic Business Overview
Table 83. Medtronic Renal Denervation Treatment Product
Table 84. Medtronic Revenue in Renal Denervation Treatment Business (2016-2021) & (US$ Million)
Table 85. Medtronic Recent Development
Table 86. Kona medical Company Details
Table 87. Kona medical Business Overview
Table 88. Kona medical Renal Denervation Treatment Product
Table 89. Kona medical Revenue in Renal Denervation Treatment Business (2016-2021) & (US$ Million)
Table 90. Kona medical Recent Development
Table 91. Mercator Medsystems Company Details
Table 92. Mercator Medsystems Business Overview
Table 93. Mercator Medsystems Renal Denervation Treatment Product
Table 94. Mercator Medsystems Revenue in Renal Denervation Treatment Business (2016-2021) & (US$ Million)
Table 95. Mercator Medsystems Recent Development
Table 96. Terumo Corporation Company Details
Table 97. Terumo Corporation Business Overview
Table 98. Terumo Corporation Revenue in Renal Denervation Treatment Business (2016-2021) & (US$ Million)
Table 99. Terumo Corporation Recent Development
Table 100. Abbott Laboratories Company Details
Table 101. Abbott Laboratories Business Overview
Table 102. Abbott Laboratories Renal Denervation Treatment Product
Table 103. Abbott Laboratories Revenue in Renal Denervation Treatment Business (2016-2021) & (US$ Million)
Table 104. Abbott Laboratories Recent Development
Table 105. Theragenics Corporation Company Details
Table 106. Theragenics Corporation Business Overview
Table 107. Theragenics Corporation Renal Denervation Treatment Product
Table 108. Theragenics Corporation Revenue in Renal Denervation Treatment Business (2016-2021) & (US$ Million)
Table 109. Theragenics Corporation Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Renal Denervation Treatment Market Share by Type: 2020 VS 2027
Figure 2. Radiofrequency Features
Figure 3. Ultrasound Features
Figure 4. Global Renal Denervation Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Ambulatory Surgical Centers Case Studies
Figure 7. Others Case Studies
Figure 8. Renal Denervation Treatment Report Years Considered
Figure 9. Global Renal Denervation Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Renal Denervation Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Renal Denervation Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Renal Denervation Treatment Market Share by Regions (2022-2027)
Figure 13. Global Renal Denervation Treatment Market Share by Players in 2020
Figure 14. Global Top Renal Denervation Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Renal Denervation Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Renal Denervation Treatment Revenue in 2020
Figure 16. Global Renal Denervation Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Renal Denervation Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Renal Denervation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Renal Denervation Treatment Market Share by Type (2016-2027)
Figure 20. North America Renal Denervation Treatment Market Share by Application (2016-2027)
Figure 21. North America Renal Denervation Treatment Market Share by Country (2016-2027)
Figure 22. United States Renal Denervation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Renal Denervation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Renal Denervation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Renal Denervation Treatment Market Share by Type (2016-2027)
Figure 26. Europe Renal Denervation Treatment Market Share by Application (2016-2027)
Figure 27. Europe Renal Denervation Treatment Market Share by Country (2016-2027)
Figure 28. Germany Renal Denervation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Renal Denervation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Renal Denervation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Renal Denervation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Renal Denervation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Renal Denervation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Renal Denervation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Renal Denervation Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Renal Denervation Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Renal Denervation Treatment Market Share by Region (2016-2027)
Figure 38. China Renal Denervation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Renal Denervation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Renal Denervation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Renal Denervation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Renal Denervation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Renal Denervation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Renal Denervation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Renal Denervation Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Renal Denervation Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Renal Denervation Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Renal Denervation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Renal Denervation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Renal Denervation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Renal Denervation Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Renal Denervation Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Renal Denervation Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Renal Denervation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Renal Denervation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Renal Denervation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Abbott Revenue Growth Rate in Renal Denervation Treatment Business (2016-2021)
Figure 58. ReCor Medical Revenue Growth Rate in Renal Denervation Treatment Business (2016-2021)
Figure 59. Boston Scientific Revenue Growth Rate in Renal Denervation Treatment Business (2016-2021)
Figure 60. Cardiosonic Revenue Growth Rate in Renal Denervation Treatment Business (2016-2021)
Figure 61. Medtronic Revenue Growth Rate in Renal Denervation Treatment Business (2016-2021)
Figure 62. Kona medical Revenue Growth Rate in Renal Denervation Treatment Business (2016-2021)
Figure 63. Mercator Medsystems Revenue Growth Rate in Renal Denervation Treatment Business (2016-2021)
Figure 64. Terumo Corporation Revenue Growth Rate in Renal Denervation Treatment Business (2016-2021)
Figure 65. Abbott Laboratories Revenue Growth Rate in Renal Denervation Treatment Business (2016-2021)
Figure 66. Theragenics Corporation Revenue Growth Rate in Renal Denervation Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed